Compare AORT & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AORT | PRGO |
|---|---|---|
| Founded | 1984 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | 1996 | 2013 |
| Metric | AORT | PRGO |
|---|---|---|
| Price | $38.57 | $12.03 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $49.40 | $19.33 |
| AVG Volume (30 Days) | 415.0K | ★ 3.1M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 9.83% |
| EPS Growth | ★ 165.62 | N/A |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $298,836,000.00 | $800,000.00 |
| Revenue This Year | $14.20 | N/A |
| Revenue Next Year | $11.20 | $1.02 |
| P/E Ratio | $179.90 | ★ N/A |
| Revenue Growth | ★ 18.01 | N/A |
| 52 Week Low | $22.68 | $9.23 |
| 52 Week High | $48.25 | $28.44 |
| Indicator | AORT | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 58.61 | 64.27 |
| Support Level | $34.15 | $9.24 |
| Resistance Level | $44.29 | $15.08 |
| Average True Range (ATR) | 1.37 | 0.51 |
| MACD | 0.39 | 0.26 |
| Stochastic Oscillator | 92.17 | 96.96 |
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.